Eterna Therapeutics Stock Price History
| ERNA Stock | USD 0.27 0.01 3.36% |
Below is the normalized historical share price chart for Eterna Therapeutics extending back to August 29, 1991. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Eterna Therapeutics stands at 0.27, as last reported on the 21st of March, with the highest price reaching 0.28 and the lowest price hitting 0.26 during the day.
If you're considering investing in Eterna Stock, it is important to understand the factors that can impact its price. Eterna Therapeutics appears to be out of control, given 3 months investment horizon. Eterna Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0615, which denotes the company had a 0.0615 % return per unit of risk over the last 3 months. By reviewing Eterna Therapeutics' technical indicators, you can evaluate if the expected return of 0.69% is justified by implied risk. Please utilize Eterna Therapeutics' Downside Deviation of 8.51, mean deviation of 6.67, and Coefficient Of Variation of 3451.69 to check if our risk estimates are consistent with your expectations.
As of March 21, 2025, Total Stockholder Equity is expected to decline to about 1.6 M. In addition to that, Common Stock Shares Outstanding is expected to decline to about 13 M. At present, Eterna Therapeutics' Price Book Value Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 4.16, whereas Price To Sales Ratio is forecasted to decline to 6.55. Eterna Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 19th of October 1992 | 200 Day MA 1.0583 | 50 Day MA 0.3438 | Beta 7.329 |
Eterna |
Sharpe Ratio = 0.0615
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ERNA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 11.24 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.69 actual daily | 13 87% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Eterna Therapeutics is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Eterna Therapeutics by adding it to a well-diversified portfolio.
Price Book 8.1471 | Enterprise Value Ebitda (0.29) | Price Sales 24.1917 | Shares Float 20.5 M | Wall Street Target Price 3 |
Eterna Therapeutics Stock Price History Chart
There are several ways to analyze Eterna Stock price data. The simplest method is using a basic Eterna candlestick price chart, which shows Eterna Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | January 22, 2025 | 0.64 |
| Lowest Price | December 19, 2024 | 0.25 |
Eterna Therapeutics March 21, 2025 Stock Price Synopsis
Various analyses of Eterna Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Eterna Stock. It can be used to describe the percentage change in the price of Eterna Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Eterna Stock.| Eterna Therapeutics Accumulation Distribution | 10,111 | |
| Eterna Therapeutics Price Rate Of Daily Change | 0.97 | |
| Eterna Therapeutics Price Daily Balance Of Power | (0.47) |
Eterna Therapeutics March 21, 2025 Stock Price Analysis
Eterna Stock Price History Data
The price series of Eterna Therapeutics for the period between Sat, Dec 21, 2024 and Fri, Mar 21, 2025 has a statistical range of 0.39 with a coefficient of variation of 25.19. Under current investment horizon, the daily prices are spread out with arithmetic mean of 0.33. The median price for the last 90 days is 0.3. The company completed 1:20 stock split on 17th of October 2022.| Open | High | Low | Close | Volume | ||
| 03/20/2025 | 0.28 | 0.28 | 0.26 | 0.27 | 141,549 | |
| 03/19/2025 | 0.28 | 0.28 | 0.26 | 0.28 | 83,241 | |
| 03/18/2025 | 0.27 | 0.28 | 0.27 | 0.27 | 53,754 | |
| 03/17/2025 | 0.26 | 0.28 | 0.26 | 0.27 | 81,854 | |
| 03/14/2025 | 0.25 | 0.27 | 0.25 | 0.26 | 176,503 | |
| 03/13/2025 | 0.25 | 0.26 | 0.25 | 0.26 | 97,331 | |
| 03/12/2025 | 0.27 | 0.28 | 0.26 | 0.26 | 172,504 | |
| 03/11/2025 | 0.27 | 0.28 | 0.25 | 0.27 | 195,213 | |
| 03/10/2025 | 0.28 | 0.28 | 0.27 | 0.27 | 56,673 | |
| 03/07/2025 | 0.28 | 0.30 | 0.28 | 0.29 | 87,862 | |
| 03/06/2025 | 0.27 | 0.30 | 0.27 | 0.29 | 69,200 | |
| 03/05/2025 | 0.30 | 0.30 | 0.27 | 0.28 | 63,563 | |
| 03/04/2025 | 0.27 | 0.29 | 0.26 | 0.29 | 205,051 | |
| 03/03/2025 | 0.30 | 0.30 | 0.28 | 0.28 | 402,710 | |
| 02/28/2025 | 0.28 | 0.30 | 0.27 | 0.30 | 278,565 | |
| 02/27/2025 | 0.29 | 0.30 | 0.28 | 0.29 | 143,044 | |
| 02/26/2025 | 0.30 | 0.33 | 0.29 | 0.30 | 176,603 | |
| 02/25/2025 | 0.29 | 0.30 | 0.28 | 0.29 | 138,600 | |
| 02/24/2025 | 0.31 | 0.33 | 0.29 | 0.30 | 218,256 | |
| 02/21/2025 | 0.34 | 0.34 | 0.31 | 0.31 | 584,673 | |
| 02/20/2025 | 0.33 | 0.36 | 0.33 | 0.34 | 351,400 | |
| 02/19/2025 | 0.30 | 0.37 | 0.29 | 0.35 | 980,502 | |
| 02/18/2025 | 0.31 | 0.32 | 0.28 | 0.30 | 684,600 | |
| 02/14/2025 | 0.31 | 0.32 | 0.28 | 0.31 | 817,424 | |
| 02/13/2025 | 0.26 | 0.30 | 0.26 | 0.29 | 646,800 | |
| 02/12/2025 | 0.27 | 0.28 | 0.25 | 0.26 | 800,940 | |
| 02/11/2025 | 0.32 | 0.32 | 0.26 | 0.26 | 929,591 | |
| 02/10/2025 | 0.33 | 0.35 | 0.30 | 0.32 | 603,198 | |
| 02/07/2025 | 0.34 | 0.37 | 0.32 | 0.34 | 553,100 | |
| 02/06/2025 | 0.34 | 0.36 | 0.33 | 0.34 | 235,038 | |
| 02/05/2025 | 0.34 | 0.36 | 0.31 | 0.32 | 924,300 | |
| 02/04/2025 | 0.36 | 0.37 | 0.35 | 0.36 | 463,700 | |
| 02/03/2025 | 0.37 | 0.37 | 0.33 | 0.36 | 561,600 | |
| 01/31/2025 | 0.38 | 0.40 | 0.37 | 0.38 | 401,500 | |
| 01/30/2025 | 0.43 | 0.44 | 0.36 | 0.37 | 1,173,200 | |
| 01/29/2025 | 0.44 | 0.44 | 0.41 | 0.43 | 410,900 | |
| 01/28/2025 | 0.44 | 0.47 | 0.43 | 0.44 | 247,000 | |
| 01/27/2025 | 0.53 | 0.56 | 0.43 | 0.44 | 1,025,500 | |
| 01/24/2025 | 0.59 | 0.62 | 0.55 | 0.57 | 771,700 | |
| 01/23/2025 | 0.56 | 0.61 | 0.53 | 0.58 | 2,101,800 | |
| 01/22/2025 | 0.47 | 0.74 | 0.44 | 0.64 | 12,738,100 | |
| 01/21/2025 | 0.40 | 0.48 | 0.38 | 0.47 | 1,517,500 | |
| 01/17/2025 | 0.43 | 0.50 | 0.40 | 0.42 | 2,561,400 | |
| 01/16/2025 | 0.42 | 0.48 | 0.39 | 0.45 | 5,524,600 | |
| 01/15/2025 | 0.51 | 0.52 | 0.38 | 0.44 | 17,743,400 | |
| 01/14/2025 | 0.51 | 0.96 | 0.43 | 0.46 | 576,003,100 | |
| 01/13/2025 | 0.31 | 0.32 | 0.29 | 0.31 | 232,000 | |
| 01/10/2025 | 0.31 | 0.33 | 0.29 | 0.30 | 301,300 | |
| 01/08/2025 | 0.34 | 0.35 | 0.30 | 0.32 | 440,100 | |
| 01/07/2025 | 0.32 | 0.36 | 0.32 | 0.33 | 249,100 | |
| 01/06/2025 | 0.30 | 0.37 | 0.30 | 0.33 | 567,400 | |
| 01/03/2025 | 0.32 | 0.37 | 0.32 | 0.34 | 859,200 | |
| 01/02/2025 | 0.32 | 0.39 | 0.31 | 0.37 | 2,799,200 | |
| 12/31/2024 | 0.32 | 0.35 | 0.28 | 0.29 | 2,001,500 | |
| 12/30/2024 | 0.28 | 0.34 | 0.27 | 0.28 | 1,421,200 | |
| 12/27/2024 | 0.29 | 0.29 | 0.25 | 0.25 | 338,000 | |
| 12/26/2024 | 0.25 | 0.30 | 0.24 | 0.28 | 608,100 | |
| 12/24/2024 | 0.26 | 0.26 | 0.25 | 0.25 | 124,200 | |
| 12/23/2024 | 0.25 | 0.26 | 0.23 | 0.25 | 263,300 | |
| 12/20/2024 | 0.24 | 0.26 | 0.24 | 0.25 | 425,200 | |
| 12/19/2024 | 0.28 | 0.28 | 0.22 | 0.25 | 695,700 |
About Eterna Therapeutics Stock history
Eterna Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Eterna is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Eterna Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Eterna Therapeutics stock prices may prove useful in developing a viable investing in Eterna Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 13.6 M | 13 M | |
| Net Loss | -22.1 M | -21 M |
Eterna Therapeutics Stock Technical Analysis
Eterna Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Idea Breakdown Now
Idea BreakdownAnalyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
| All Next | Launch Module |
Eterna Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Eterna Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Eterna Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Eterna to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0349 | |||
| Jensen Alpha | 0.3658 | |||
| Total Risk Alpha | 1.21 | |||
| Sortino Ratio | 0.0443 | |||
| Treynor Ratio | 0.3578 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Eterna Stock analysis
When running Eterna Therapeutics' price analysis, check to measure Eterna Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eterna Therapeutics is operating at the current time. Most of Eterna Therapeutics' value examination focuses on studying past and present price action to predict the probability of Eterna Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eterna Therapeutics' price. Additionally, you may evaluate how the addition of Eterna Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |